Status:
UNKNOWN
Bronchodilators on the Exercise Capacity of Bronchiectasis Patients
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Bronchiectasis Adult
Eligibility:
All Genders
18-59 years
Phase:
NA
Brief Summary
The bronchodilators (BD) have been widely used in bronchiectasis (BCE) therapeutic and have been shown to be effective in improving exercise capacity in patients with chronic obstructive pulmonary dis...
Detailed Description
This is a randomized, double-blind, crossover, placebo-controlled trial. Forty clinically stable patients with bronchiectasis (BCE), all sexes, 18 to 59 years, will be evaluated in two non-consecutive...
Eligibility Criteria
Inclusion
- All sexes
- 18 to 59 years
- Bronchiectasis diagnosis, according to thorax the Computed Tomography (Pasteur et al., 2010)
- Clinically stable (last 30 days without exacerbation/hospitalization)
- Air trapping on plethysmography (Residual Volume/Total Lung Capacity\>125%)
- Smoking Load \<10 pack-years
Exclusion
- Do not accept to participate
- Smoking
- Continuous oxygen use
- Pulmonary Rehabilitation program in the last 6 months
- Previous lung resection
- Uncontrolled cardiovascular disease
- Other respiratory chronic diseases
- Neurological or musculoskeletal disorders that limit exercise
- Cognitive deficits that limit comprehension
Key Trial Info
Start Date :
April 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05183841
Start Date
April 14 2022
End Date
November 1 2025
Last Update
December 11 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Celso Ricardo Fernandes de Carvalho
São Paulo, Brazil, 01246903
2
Clinical Hospital of Sao Paulo University Medical School (HCFMUSP)
São Paulo, Brazil, 05360000
3
Clinical Hospital of Sao Paulo University Medical School
São Paulo, Brazil, 05360000